Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine.

Autor: Nemunaitis, J1, Senzer, N1, Olivares, J2, Kumar, P3, Barve, M2, Kuhn, J4, Nemunaitis, T3, Magee, M5, Yu, Y3, Wallraven, G3, Pappen, B O3, Maples, P B3
Zdroj: Gene Therapy. Sep2013, Vol. 20 Issue 9, p875-879. 5p.
Databáze: Academic Search Ultimate